Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tarsus Pharmaceuticals, Inc.

Clinical trials sponsored by Tarsus Pharmaceuticals, Inc., explained in plain language.

Tarsus Pharmaceuticals, Inc. TARS NASDAQ

Develops therapies for ophthalmic and dermatologic conditions.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 2 Completed 1

New eyedrop shows promise for Mite-Related dry eye

Disease control Completed

This study tested an eyedrop called TP-03 in 39 people with meibomian gland dysfunction (a common cause of dry eye) linked to Demodex mites. The goal was to compare two dosing schedules (twice vs. three times daily) for safety and effectiveness. The results could lead to a new tr…

Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC